Login

Delisting Not on the Agenda" | Francis Van Eeckhout (Deceuninck) | CEO Talk | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Financial Experiences | Broota: The Leading Crowdfunding Platform - José Antonio Berríos | CEO and Founder, Broota
00:10:00
Strategic Perspectives on Growth: A Deep Dive into Capital Allocation and Economic Trends | Scott Sperling, CO-CEO, Thomas H. Lee Partners .
00:10:00
"Navigating Economic Uncertainty: Insights from JNBA's Investment Committee" | Richard S. Brown - CHAIRMAN & CHIEF EXECUTIVE OFFICER of JNBA Financial Advisors
00:10:00
A Day in the Life of Thomas Moore | Thomas Moore - Fund Manager, abrdn Equity Income Trust
00:10:00
Australia's Mineral Resources Identified | James Johnson, Chief Executive Officer at Geoscience Australia
00:10:00
Interview with Jimmy Lin: New Horizons Capital at the One-to-One Mining Conference
00:10:00
Navigating the Q3 Economy: Insights from Syverson Strege | Jason Gunkel, Chief Investment Officer, Financial Planner of Syverson Strege
00:10:00
Chris Barnes, CEO of Tracsis Plc, Recognized for Driving Ambition in finnCap Ambition Nation Listed 50
00:10:00
Thomas Wynn, Managing Director at MacKay Shields, predicts that a rise in rates will lead to increased volatility, impacting convertibles.|Naïm Abou-Jaoudé currently serves as Chairman and Interim CEO of MacKay Shields and is the Chief Executive Officer o
00:10:00
December 2021 Financial Review: Emergency Funds, Mortgage Limits, and Interest Rates
00:10:00
Wants to Help You Reach a Bigger Audience|Troy Osinoff,General Partner,MAGIC Fund
00:10:00
Beleave Inc. CFO Bojan Krasic Discusses Recent Developments and Expansion Plans | Bojan Krasic, CFO, Beleave Inc.

© 2026 Nehu